Subscribe to RSS - Abbott

Abbott

FDA approves Libre 2

 - 
06/19/2020

ABBOTT PARK, Ill. – Abbott has received Food and Drug Administration clearance for its Freestyle Libre 2.

Diabetes research: One Drop, Abbott

 - 
02/22/2019

One Drop has announced the results of a study demonstrating a -0.93 absolute A1c improvement among people with Type 2 diabetes who use its digital therapeutic solution and Afrezza, an inhaled insulin.

Abbott, Novo Nordisk seek to eliminate ‘hassle’

 - 
02/20/2019

ABBOTT PARK, Ill. – Abbott and Novo Nordisk have partnered to integrate insulin dose data from Novo Nordisk’s connected insulin pens with digital health tools compatible with Abbot’s FreeStyle Libre continuous glucose monitoring system.

FDA approves FreeStyle app

 - 
11/01/2018

ABBOTT PARK, Ill. – The FreeStyle LibreLink app has been approved by the U.S. Food and Drug Administration for the iPhone, according to a press release from Abbott. The app allows user to capture and view real-time glucose levels.

Abbott upgrades FreeStyle Libre

 - 
08/01/2018

ABBOTT PARK, Ill. – The U.S. Food and Drug Administration has approved Abbott’s FreeStyle Libre 14-day Flash Glucose Monitoring System.

Abbott Labs, Alere deal moves forward

 - 
04/18/2017

ABBOTT PARK, Ill., and WALTHAM, Mass. – Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.

In brief: Report cites spike in PAP use, Inogen sets IPO terms

 - 
02/07/2014

WASHINGTON – The number of beneficiaries receiving PAP devices for a one-year time period grew 13%, while the total number of beneficiaries receiving all DMEPOS items during the same period fell 1%, according to a recently released comparative billing report.

Abbott plans pediatric tube feeding webinar

 - 
02/07/2014

ABBOTT PARK, Ill. – Abbott is offering a Feb. 20 webinar on pediatric tube feeding for HME providers to gain insight to help them improve service to home enteral patients.